| Year |
Citation |
Score |
| 2018 |
Devulapally R, Lee T, Barghava-Shah A, Sekar TV, Foygel K, Bachawal SV, Willmann JK, Paulmurugan R. Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy. Nanomedicine (London, England). PMID 29790803 DOI: 10.2217/Nnm-2017-0328 |
0.757 |
|
| 2016 |
Devulapally R, Foygel K, Sekar TV, Willmann JK, Paulmurugan R. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy. Acs Applied Materials & Interfaces. 8: 33412-33422. PMID 27960411 DOI: 10.1021/Acsami.6B08153 |
0.751 |
|
| 2016 |
Oronsky B, Paulmurugan R, Foygel K, Scicinski J, Knox SJ, Peehl D, Zhao H, Ning S, Cabrales P, Summers TA, Reid TR, Fitch WL, Kim MM, Trepel JB, Lee MJ, et al. RRx-001: A Systemically Non-Toxic M2-to-M1 Macrophage Stimulating and Prosensitizing Agent In Phase II Clinical Trials. Expert Opinion On Investigational Drugs. PMID 27935336 DOI: 10.1080/13543784.2017.1268600 |
0.533 |
|
| 2016 |
Sekar TV, Foygel K, Devulapally R, Kumar V, Malhotra S, Massoud TF, Paulmurugan R. Molecular Imaging Biosensor Monitors p53 Sumoylation in Cells and Living Mice. Analytical Chemistry. 88: 11420-11428. PMID 27934110 DOI: 10.1021/Acs.Analchem.6B02048 |
0.741 |
|
| 2016 |
Calibasi Kocal G, Güven S, Foygel K, Goldman A, Chen P, Sengupta S, Paulmurugan R, Baskin Y, Demirci U. Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Scientific Reports. 6: 38221. PMID 27910892 DOI: 10.1038/Srep38221 |
0.531 |
|
| 2016 |
Sekar TV, Foygel K, Massoud TF, Gambhir SS, Paulmurugan R. A transgenic mouse model expressing an ERα folding biosensor reveals the effects of Bisphenol A on estrogen receptor signaling. Scientific Reports. 6: 34788. PMID 27721470 DOI: 10.1038/Srep34788 |
0.737 |
|
| 2016 |
Bhargava-Shah A, Foygel K, Devulapally R, Paulmurugan R. Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy. Nanomedicine (London, England). 11: 235-47. PMID 26787319 DOI: 10.2217/Nnm.15.193 |
0.777 |
|
| 2016 |
Kumar V, Foygel K, Paulmurugan R, Malhotra SV. Abstract 1363: Novel Nrf2 inhibitors and their application to overcome chemoresistance of anticancer drugs Cancer Research. 76: 1363-1363. DOI: 10.1158/1538-7445.Am2016-1363 |
0.486 |
|
| 2015 |
Paulmurugan R, Bhethanabotla R, Mishra K, Devulapally R, Foygel K, Sekar TV, Ananta JS, Massoud TF, Joy A. Folate Receptor Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple Negative Breast Cancer. Molecular Cancer Therapeutics. PMID 26553061 DOI: 10.1158/1535-7163.Mct-15-0579 |
0.779 |
|
| 2015 |
Foygel K, Sekar TV, Paulmurugan R. Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy. Plos One. 10: e0141913. PMID 26536456 DOI: 10.1371/Journal.Pone.0141913 |
0.754 |
|
| 2015 |
Devulapally R, Sekar NM, Sekar TV, Foygel K, Massoud TF, Willmann JK, Paulmurugan R. Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy. Acs Nano. 9: 2290-302. PMID 25652012 DOI: 10.1021/Nn507465D |
0.663 |
|
| 2015 |
Sekar TV, Foygel K, Gelovani JG, Paulmurugan R. Genetically encoded molecular biosensors to image histone methylation in living animals. Analytical Chemistry. 87: 892-9. PMID 25506787 DOI: 10.1021/Ac502629R |
0.714 |
|
| 2015 |
Sekar TV, Foygel K, Devulapally R, Paulmurugan R. Degron protease blockade sensor to image epigenetic histone protein methylation in cells and living animals. Acs Chemical Biology. 10: 165-74. PMID 25489787 DOI: 10.1021/Cb5008037 |
0.743 |
|
| 2014 |
Sekar TV, Foygel K, Ilovich O, Paulmurugan R. Noninvasive theranostic imaging of HSV1-sr39TK-NTR/GCV-CB1954 dual-prodrug therapy in metastatic lung lesions of MDA-MB-231 triple negative breast cancer in mice. Theranostics. 4: 460-74. PMID 24669276 DOI: 10.7150/Thno.8077 |
0.767 |
|
| 2014 |
Foygel K, Sekar TV, Paulmurugan R. Abstract 5120: Monitoring antioxidant induced chemosensitization in triple negative breast cancer cells by Nrf2-luciferase fusion protein Cancer Research. 74: 5120-5120. DOI: 10.1158/1538-7445.Am2014-5120 |
0.766 |
|
| 2013 |
Sekar TV, Mohanram RK, Foygel K, Paulmurugan R. Therapeutic evaluation of microRNAs by molecular imaging. Theranostics. 3: 964-85. PMID 24396507 DOI: 10.7150/Thno.4928 |
0.739 |
|
| 2013 |
Ramkumar KM, Sekar TV, Foygel K, Elango B, Paulmurugan R. Reporter protein complementation imaging assay to screen and study Nrf2 activators in cells and living animals. Analytical Chemistry. 85: 7542-9. PMID 23826874 DOI: 10.1021/Ac401569J |
0.739 |
|
| 2013 |
Ramkumar KM, Sekar TV, Bhakkiyalakshmi E, Foygel K, Rajaguru P, Berger F, Paulmurugan R. The impact of oxidative stress on islet transplantation and monitoring the graft survival by non-invasive imaging. Current Medicinal Chemistry. 20: 1127-46. PMID 23317098 DOI: 10.2174/0929867311320090003 |
0.699 |
|
| 2012 |
Sekar TV, Foygel K, Willmann JK, Paulmurugan R. Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging. Gene Therapy. 20: 529-37. PMID 22914496 DOI: 10.1038/Gt.2012.66 |
0.747 |
|
| 2012 |
Pysz MA, Seeley ES, Foygel K, Gambhir SS, Tian L, Brentnall TA, Willmann JK. Abstract LB-509: Early detection of pancreatic cancer in transgenic mice with ultrasonic molecular imaging and VEGFR2-targeted microbubbles Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-509 |
0.435 |
|
| 2010 |
Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology. 256: 519-27. PMID 20515975 DOI: 10.1148/Radiol.10091858 |
0.464 |
|
| Show low-probability matches. |